Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy
Abstract
Objective: Sodium-coupled transporters remove extracellular neurotransmitters and alterations in their function could enhance or suppress synaptic transmission and seizures. This study determined hippocampal gamma-aminobutyric acid (GABA) and glutamate transporter immunoreactivity (IR) in temporal lobe epilepsy (TLE) patients.
Methods: Hippocampal sclerosis (HS) patients (n = 25) and non-HS cases (mass lesion and cryptogenic; n = 20) were compared with nonseizure autopsies (n = 8). Hippocampal sections were studied for neuron densities along with IR for glutamate decarboxylase (GAD; presynaptic GABA terminals), GABA transporter-1 (GAT-1; presynaptic GABA transporter), GAT-3 (astrocytic GABA transporter), excitatory amino acid transporter 3 (EAAT3; postsynaptic glutamate transporter), and EAAT2-1 (glial glutamate transporters).
Results: Compared with autopsies, non-HS cases with similar neuron counts showed: 1) increased GAD IR gray values (GV) in the fascia dentata outer molecular layer (OML), hilus, and stratum radiatum; 2) increased GAT-1 OML GVs; 3) increased astrocytic GAT-3 GVs in the hilus and Ammon’s horn; and 4) no IR differences for EAAT3-1. HS patients with decreased neuron densities demonstrated: 1) increased OML and inner molecular layer GAD puncta; 2) decreased GAT-1 puncta relative to GAD in the stratum granulosum and pyramidale; 3) increased GAT-1 OML GVs; 4) decreased GAT-3 GVs; 5) increased EAAT3 IR on remaining granule cells and pyramids; 6) decreased glial EAAT2 GVs in the hilus and CA1 stratum radiatum associated with neuron loss; and 7) increased glial EAAT1 GVs in CA2/3 stratum radiatum.
Conclusions: Hippocampal GABA and glutamate transporter IR differ in TLE patients compared with autopsies. These data support the hypothesis that excitatory and inhibitory neurotransmission and seizure susceptibility could be altered by neuronal and glial transporters in TLE patients.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Attwell D, Barbour B, Szatkowski M. Nonvesicular release of neurotransmitter. Neuron 1993;11:401–407.
2.
Storm-Mathisen J. Localization of transmitter candidates in the brain : the hippocampal formation as a model. Prog Neurobiol 1977;8:119–181.
3.
Logan WJ, Synder SH. Unique high affinity uptake systems for glycine, glutamic and aspartic acids in the central nervous tissue in the rat. Nature 1971;234:297–299.
4.
Kanner BI, Sharon I. Active transport of L-glutamate by membrane vesicles isolated from rat brain. Biochemistry 1978;17:3949–3953.
5.
Danbolt NC, Storm-Mathisen J, Ottersen OP. Sodium/potassium-coupled glutamate transporters, a “new” family of eukaryotic proteins : do they have “new” physiological roles and could they be new targets for pharmacological intervention? Prog Brain Res 1994;100:53–60.
6.
Miller JW, Kleven DT, Domin BA, Fremeau RT Jr. Cloned sodium- (and chloride-) dependent high-affinity transporters for GABA, glycine, proline, betaine, taurine, and creatine. In: Reith MEA, ed. Neurotransmitter transporters: structure, function, and regulation. Totowa, NJ:Humana Press, 1997:101–150.
7.
Kanai Y, Trotti D, Nussberger S, Hediger MA. The high-affinity glutamate transporter family. In: Reith MEA, ed. Neurotransmitter transporters: Structure, function and regulation. Totowa, NJ:Humana Press, 1997:171–213.
8.
Haycock JW, Levy WB, Denner LA, Cotman CW. Effects of elevated [K+]O on the release of neurotransmitters from cortical synaptosomes : efflux or secretion? J Neurochem 1978;30:1113–1125.
9.
Pin J-P, Bockaert J. Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J Neurosci 1989;9:648–656.
10.
Nelson H, Mandiyan S, Nelson N. Cloning of the human brain GABA transporter. FEBS Lett 1990;269:181–184.
11.
Borden LA, Murali Dhar TG, Smith KE, Branchek TA, Gluchowski C, Weinshank RL. Cloning of the human homologue of the GABA transporter GAT-3 and identification of a novel inhibitor with selectivity for this site. Recep Chan 1994;2:207–213.
12.
Liu Q-R, López-Corcuera B, Mandiyan S, Nelson H, Nelson N. Molecular characterization of four pharmacologically distinct α-aminobutyric acid transporters in mouse brain. J Biol Chem 1993;268:2106–2112.
13.
Borden LA. GABA transporter heterogeneity : pharmacology and cellular localization. Neurochem Int 1996;29:335–356.
14.
Radian R, Ottersen OP, Storm-Mathisen J, Castel M, Kanner BI. Immunocytochemical localization of the GABA transporter in rat brain. J Neurosci 1990;10:1319–1330.
15.
Ribak CE, Tong WMY, Brecha NC. GABA plasma membrane transporters, GAT-1 and GAT-3, display different distributions in the rat hippocampus. J Comp Neurol 1996;367:595–606.
16.
Pines G, Danbolt NC, Bjørås M, et al. Cloning and expression of a rat brain L-glutamate transporter. Nature 1992;360:464–467.
17.
Kanai Y, Hediger MA. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992;360:467–471.
18.
Fairman WA, Vanderberg RJ, Arriza JL, Kavanaugh MP, Amara SG. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 1995;375:599–603.
19.
Arriza JL, Eliasof S, Kavanaugh MP, Amara SG. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 1997;94:4155–4160.
20.
Rothstein JD, Martin L, Levey AI, et al. Localization of neuronal and glial glutamate transporters. Neuron 1994;13:713–725.
21.
Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt NC, Storm-Mathisen J. Glutamate transporters in glial plasma membranes : highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 1995;15:711–720.
22.
Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC. Differential expression of the two glial glutamate transporters in the rat brain : quantitative and immunocytochemical observation. J Neurosci 1995;15:1835–1853.
23.
Yamada K, Watanabe M, Shibata T, Tanaka K, Wada K, Inoue Y. EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses. NeuroReport 1996;7:2013–2017.
24.
During M. In vivo neurochemistry of the conscious human brain: intrahippocampal microdialysis in epilepsy. In: Robinson TE, Justice JB, eds. Microdialysis in the neurosciences. Amsterdam:Elsevier, 1991:425–442.
25.
Do KQ, Klancnik JM, Gähwiler B, Perschak H, Wieser H-G, Cuénod M. Release of excitatory amino acids: animal studies and epileptic foci studies in human. In: Meldrum BS, Moroni F, Simon RP, Woods JH, eds. Excitatory amino acids. New York:Raven Press, 1991:677–685.
26.
Ronne-Engström E, Hillered L, Flink R, Spännare B, Ungerstedt U, Carlson H. Intracerebral microdialysis of extracellular amino acids in the human epileptic focus. J Cereb Blood Flow Metab 1992;12:873–876.
27.
During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993;341:1607–1610.
28.
During MJ, Ryder KM, Spencer DD. Hippocampal GABA transporter function in temporal lobe epilepsy. Nature 1995;376:174–177.
29.
Williamson A, Telfeian AE, Spencer DD. Prolonged GABA responses in dentate granule cells in slices isolated from patients with temporal lobe sclerosis. J Neurophysiol 1995;74:378–387.
30.
Mathern GW, Danbolt NC, Nelson N, et al. Hippocampal glutamate and GABA transporters in temporal lobe epilepsy. Epilepsia 1997;38 (suppl 3):231. Abstract.
31.
Engel J Jr, Lévesque MF, Crandall PH, Shewmon A, Rausch R, Sutherling W. The epilepsies. In: Grossman RG, ed. Principles of neurosurgery. New York:Raven Press, 1991:319–358.
32.
Wieser HG, Engel J Jr, Williamson PD, Babb TL, Gloor P. Surgically remediable temporal lobe syndromes. In: Engel J Jr, ed. Surgical treatment of the epilepsies. 2nd ed. New York:Raven Press, 1993:49–63.
33.
Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 1995;118:105–113.
34.
Mathern GW, Babb TL, Pretorius JK, Leite JP. Reactive synaptogenesis and neuron densities for neuropeptide Y, somatostatin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J Neurosci 1995;15:3990–4004.
35.
Mathern GW, Kuhlman PA, Mendoza D, Pretorius JK. Human fascia dentata stratum granulosum and hilar areas, and hippocampal neuron counts differ depending on the epileptic syndrome and age at first seizures. J Neuropathol Exp Neurol 1997;56:199–212.
36.
Babb TL, Brown WJ. Pathological findings in epilepsy. In: Engel J Jr, ed. Surgical treatment of the epilepsies. New York:Raven Press, 1987:511–540.
37.
Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: Engel J Jr, Pedley TA, eds. Epilepsy: A comprehensive textbook. New York:Raven Press, 1997:133–155.
38.
Babb TL, Brown WJ, Pretorius JK, Davenport C, Lieb JP, Crandall PH. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia 1984;25:729–740.
39.
Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946;94:239–247.
40.
Lorente de Nó R. Studies on the structure of the cerebral cortex. II. Continuation of the study of the ammonic system. J Psychol Neurol 1934;45:113–177.
41.
Amaral DG, Campbell MJ. Transmitter systems in the primate dentate gyrus. Hum Neurobiol 1986;5:169–180.
42.
Mayhew TM. A review of recent advances in stereology for quantifying neural structure. J Neurocytol 1992;21:313–328.
43.
West MJ. Stereological studies of the hippocampus : a comparison of the hippocampal subdivisions of diverse species including hedgehogs, laboratory rodents, wild mice and men. Prog Brain Res 1990;83:13–36.
44.
Babb TL, Pretorius JK, Kupfer WR, Crandall PH. Glutamate decarboxylase-immunoreactive neurons are preserved in human epileptic hippocampus. J Neurosci 1989;9:2562–2574.
45.
Mathern GW, Leite JP, Babb TL, et al. Aberrant hippocampal mossy fiber sprouting correlates with greater NMDAR2 receptor staining. NeuroReport 1996;7:1029–1035.
46.
Mathern GW, Bertram EH, Babb TL, et al. In contrast to kindled seizures, the frequency of spontaneous epilepsy in the limbic status model correlates with greater aberrant fascia dentata excitatory and inhibitory axon sprouting, and increased staining for NMDA, AMPA, and GABA-A receptors. Neuroscience 1997;77:1003–1019.
47.
Oertel WH, Schmechel DE, Tappaz ML, Kopin IJ. Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience 1981;6:2689–2700.
48.
Haugeto Ø, Ullensvang K, Levy LM, et al. Brain glutamate transporter proteins form homomultimers. J Biol Chem 1996;271:27715–27722.
49.
Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 1994;14:5559–5569.
50.
Freund TF, Buzsáki G. Interneurons of the hippocampus. Hippocampus 1996;6:347–470.
51.
Zhu Z-Q, Armstrong DL, Hamilton WJ, Grossman RG. Disproportionate loss of CA4 parvalbumin-immunoreactive interneurons in patients with Ammon’s horn sclerosis. J Neuropathol Exp Neurol 1997;56:988–998.
52.
Vezzani A, Ungerstedt U, French ED, Schwarcz R. In vivo brain dialysis of amino acids and simultaneous EEG measurements following intrahippocampal quinolinic acid injection : evidence for a dissociation between neurochemical changes and seizures. J Neurochem 1985;45:335–344.
53.
Lehmann A, Hagberg H, Jacobson I, Hamberger A. Effects of status epilepticus on extracellular amino acids in the hippocampus. Brain Res 1985;359:147–151.
54.
Millan MH, Chapman AG, Meldrum BS. Extracellular amino acid levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res 1993;14:139–148.
55.
Zhang WQ, Hudson PM, Sobotka TJ, Hong JS, Tilson HA. Extracellular concentrations of amino acid transmitters in ventral hippocampus during and after the development of kindling. Brain Res 1991;540:315–318.
56.
Bruhn T, Cobo M, Berg M, Diemer NH. Limbic seizure-induced changes in extracellular amino acid levels in the hippocampal formation : a microdialysis study of freely moving rats. Acta Neurol Scand 1992;86:455–461.
57.
Ueda Y, Tsuru N. Simultaneous monitoring of the seizure-related changes in extracellular glutamate and γ-aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling. Epilepsy Res 1995;20:213–219.
58.
Schünzel G, Wolf G, Pomrenke U, Pmrenke C, Schmidt W. Pentylenetetrazol kindling and factors of glutamate transmitter metabolism in rat hippocampus. Neuroscience 1992;49:365–371.
59.
Nadler JV, Cotman CW, Lynch GS. Biochemical plasticity of short-axon interneurons : increased glutamate decarboxylase activity in the denervated area of rat dentate gyrus following entorhinal lesion. Exp Neurol 1974;45:403–413.
60.
Nadler JV, White WF, Vaca KW, Cotman CW. Calcium-dependent γ-aminobutyrate release by interneurons of rat hippocampal regions : lesion-induced plasticity. Brain Res 1977;131:241–258.
61.
Deller T, Frotscher M, Nitsch R. Morphological evidence for the sprouting of inhibitory commissural fibers in response to the lesion of the excitatory entorhinal input to the rat dentate gyrus. J Neurosci 1995;15:6868–6878.
62.
Akbar MT, Torp R, Danbolt NC, Levy LM, Meldrum BS, Ottersen OP. Expression of glial glutamate transporters GLT-1 and GLAST is unchanged in the hippocampus in fully kindled rats. Neuroscience 1997;78:351–359.
63.
Levy LM, Lehre KP, Walaas I, Storm-Mathisen J, Danbolt NC. Downregulation of a glial glutamate transporter in striatum after destruction of the glutamatergic corticostriatal projection. J Neurochem 1993;61:S208. Abstract.
64.
Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73–84.
65.
Kiryu S, Yao GL, Morita N, Kato H, Kiyama H. Nerve injury enhances rat neuronal glutamate transporter expression : identification by differential display PCR. J Neurosci 1995;15:7872–7878.
66.
Ginsberg SD, Rothstein JD, Price DL, Martin LJ. Fimbria-fornix transections selectively down-regulate subtypes of glutamate transporter and glutamate receptor proteins in septum and hippocampus. J Neurochem 1996;67:1208–1216.
67.
Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675–686.
68.
Torp R, Lekieffre D, Levy LM, et al. Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus. Exp Brain Res 1995;103:51–58.
69.
Chan PH, Kerlan R, Fishman RA. Reductions of γ-aminobutyric acid and glutamate uptake and (Na+ + K+)-ATPase activity in brain slices and synaptosomes by arachodonic acid. J Neurochem 1983;40:309–316.
70.
Trotti D, Rizzini BL, Rossi D, et al. Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism. Eur J Neurosci 1997;9:1236–1243.
71.
Casado M, Bendahan A, Zafra F, et al. Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J Biol Chem 1993;268:27313–27317.
72.
Mouritzen-Dam A. Epilepsy and neuron loss in the hippocampus. Epilepsia 1980;21:617–629.
73.
Otis TS, Wu Y-C, Trussell LO. Delayed clearance of transmitter and the role of glutamate transporters at synapses with multiple release sites. J Neurosci 1996;16:1634–1644.
74.
Isaacson JS, Solis JM, Nicoll RA. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 1993;10:165–175.
75.
Destexhe A, Sejnowski TJ. G protein activation kinetics and spillover of γ-aminobutyric acid may account for differences between inhibitory responses in the hippocampus and thalamus. Proc Natl Acad Sci USA 1995;92:9515–9519.
76.
Obrenovitch TP, Urenjak J. Altered glutamatergic transmission in neurological disorders : from high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol 1997;51:39–87.
77.
Dingledine R, Korn SJ. γ-Aminobutyric acid uptake and the termination of inhibitory synaptic potentials in the rat hippocampal slice. J Physiol (London) 1985;366:387–409.
78.
Sarantis M, Ballerini L, Miller B, Silver RA, Edwards M, Attwell D. Glutamate uptake from the synaptic cleft does not shape the decay of the non-NMDA component of the synaptic current. Neuron 1993;11:541–549.
79.
Asztely F, Erdemli G, Kullmann DM. Extrasynaptic glutamate spillover in the hippocampus : dependence on temperature and the role of active glutamate uptake. Neuron 1997;18:281–293.
80.
Gibbs JW, Shumate MD, Coulter DA. Differential epilepsy-associated alterations in postsynaptic GABAA receptor function in dentate granule and CA1 neurons. J Neurophysiol 1997;77:1924–1938.
81.
Mathern GW, Pretorius JK, Kornblum HI, et al. Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy. Brain 1997;120:1937–1959.
82.
Mathern GW, Pretorius JK, Mendoza D, et al. Increased hippocampal AMPA and NMDA receptor subunit immunoreactivity in temporal lobe epilepsy patients. J Neuropathol Exp Neurol 1998;57:615–634.
83.
Mathern GW, Pretorius JK, Kornblum HI, et al. Altered hippocampal kainate-receptor mRNA levels in temporal lobe epilepsy patients. Neurobiol Dis 1998;5:151–176.
Information & Authors
Information
Published In
Copyright
© 1999.
Publication History
Received: May 26, 1998
Accepted: November 23, 1998
Published online: February 1, 1999
Published in print: February 1, 1999
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Glutamate transporters in health and disease, Two Sides of the Same Coin - Glutamate in Health and Disease [Working Title], (2024).https://doi.org/10.5772/intechopen.1005544
- Analysis of the Functional State of Astroglia in the Hippocampus of Rats Genetically Prone to Audiogenic Seizures, Journal of Evolutionary Biochemistry and Physiology, 59, 6, (1924-1934), (2024).https://doi.org/10.1134/S0022093023060030
- Development towards a novel screening method for nipecotic acid bioisosteres using molecular imprinted polymers (MIPs) as alternative to in vitro cellular uptake assays, Talanta, 278, (126500), (2024).https://doi.org/10.1016/j.talanta.2024.126500
- Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy, Frontiers in Neuroscience, 17, (2023).https://doi.org/10.3389/fnins.2023.1217702
- ANALYSIS OF THE FUNCTIONAL STATE OF ASTROGLIA IN THE HIPPOCAMPUS OF RATS GENETICALLY PRONE TO AUDIOGENIC SEIZURES, Журнал эволюционной биохимии и физиологии, 59, 6, (475-484), (2023).https://doi.org/10.31857/S0044452923060049
- Visualizing GABA transporters in vivo: an overview of reported radioligands and future directions, EJNMMI Research, 13, 1, (2023).https://doi.org/10.1186/s13550-023-00992-5
- E2730, an uncompetitive γ‐aminobutyric acid transporter‐1 inhibitor, suppresses epileptic seizures in a rat model of chronic mesial temporal lobe epilepsy, Epilepsia, 64, 10, (2806-2817), (2023).https://doi.org/10.1111/epi.17735
- Therapeutic targets and future directions, Posttraumatic Epilepsy, (169-181), (2023).https://doi.org/10.1016/B978-0-323-90099-7.00014-9
- Epilepsy, Neurobiology of Brain Disorders, (753-780), (2023).https://doi.org/10.1016/B978-0-323-85654-6.00060-5
- The Role of Neurotransmitters in Epileptogenesis: Focus on GABA and Glutamate, Handbook of Neurodegenerative Disorders, (1-13), (2023).https://doi.org/10.1007/978-981-19-3949-5_17-2
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.